Regional expansion Jamjoom Pharma is actively expanding manufacturing capabilities in Saudi Arabia and Western Asia, including a recent facility acquisition from Pfizer in KAEC. This presents cross-border selling opportunities for pharma products and contract manufacturing services to support sustained regional growth.

Strategic partnerships Recent collaborations with Idorsia for dementia insomnia treatment distribution and with Viatris for local manufacturing of chronic disease products indicate a strong channel strategy and co-manufacturing potential to broaden product reach and accelerate market access.

Public sector alignment MOH collaboration to develop healthcare talent signals government-backed demand and potential tender opportunities, training programs, and public procurement channels that can be leveraged for scalable product supply and localization initiatives.

Localization leadership With a Saudi Vision 2030 focus on local content and national health security, there are scalable opportunities to partner on local manufacturing, technology transfer, and supply chain resilience programs that can drive new product registrations and regional tenders.

Diverse product ecosystem A revenue base across 36 countries and a diversified tech stack plus recent capacity expansion positions Jamjoom as a reliable manufacturing and distribution partner for chronic disease portfolios, enabling cross-selling of existing and new products to regional distributors and healthcare providers.